Stem cell therapy for HTLV-1 induced adult T-cell leukemia/lymphoma (ATLL): A comprehensive review
Pathology - Research and Practice · 2024
DOI: 10.1016/j.prp.2024.155172 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Amir Gholamzad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: Leukemia-Lymphoma, Adult T-Cell, Human T-lymphotropic virus 1, Hematopoietic Stem Cell Transplantation, Lymphoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 174 Literaturangaben.
Abstract (Originalsprache)
Adult T-cell leukemia/lymphoma (ATLL) is a rare and aggressive form of cancer associated with human T-cell lymphotropic virus type 1 (HTLV-1) infection. The emerging field of stem cell therapies for ATLL is discussed, highlighting the potential of hematopoietic stem cell transplantation (HSCT) and genetically modified stem cells. HSCT aims to eradicate malignant T-cells and restore a functional immune system through the infusion of healthy donor stem cells. Genetically modified stem cells show promise in enhancing their ability to target and eliminate ATLL cells. The article presents insights from preclinical studies and limited clinical trials, emphasizing the need for further research to establish the safety, efficacy, and long-term outcomes of stem cell therapies for ATLL and challenges associated with these innovative approaches are also explored. Overall, stem cell therapies hold significant potential in revolutionizing ATLL treatment, and ongoing clinical trials aim to determine their benefits in larger patient populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
- Department of Bacteriology and Virology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Microbiology and Immunology, Faculty of Medicine, Islamic Azad University of Medical Science, Tehran, Iran. Electronic address: Mgholamzad@iautmu.ac.ir.
- Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
- The Health of Plant and Livestock Products Research Center, Mazandaran University of Medical Sciences, Sari, Iran; Department Pharmacology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. Ele…
- Farhikhtegan Medical Convergence Sciences Research Center, Farhikhtegan Hospital Tehran Medical Sciences, Islamic Azad University, Tehran, Iran; Department of Genetics, Faculty of Advanced Science and Technology, Tehran…
Zitieren
APA
Gholamzad, A., Khakpour, N., Gholamzad, M., Roudaki Sarvandani, M. R., Khosroshahi, E. M., Asadi, S., Rashidi, M., & Hashemi, M. (2024). Stem cell therapy for HTLV-1 induced adult T-cell leukemia/lymphoma (ATLL): A comprehensive review. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155172
Vancouver
Gholamzad A, Khakpour N, Gholamzad M, Roudaki Sarvandani MR, Khosroshahi EM, Asadi S, et al. Stem cell therapy for HTLV-1 induced adult T-cell leukemia/lymphoma (ATLL): A comprehensive review. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155172
BibTeX
@article{Gholamzad2024,
author = {Gholamzad, Amir and Khakpour, Niloofar and Gholamzad, Mehrdad and Roudaki Sarvandani, Mohammad Reza and Khosroshahi, Elaheh Mohandesi and Asadi, Saba and Rashidi, Mohsen and Hashemi, Mehrdad},
title = {Stem cell therapy for HTLV-1 induced adult T-cell leukemia/lymphoma (ATLL): A comprehensive review},
journal = {Pathology - Research and Practice},
year = {2024},
doi = {10.1016/j.prp.2024.155172}
}
EUVIMED